Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

[1]  B. Bogerts,et al.  Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[3]  P. Buckley,et al.  Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses , 2013, Brain, Behavior, and Immunity.

[4]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[5]  D. C. Cara,et al.  Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression. , 2013, The Journal of nutritional biochemistry.

[6]  H. Drexhage,et al.  Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders , 2013, Journal of Neuroimmune Pharmacology.

[7]  M. Maes,et al.  In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS‐damaged neoepitopes , 2013, Acta psychiatrica Scandinavica.

[8]  Marilyn A Winkleby,et al.  Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. , 2013, The American journal of psychiatry.

[9]  M. Cairns,et al.  Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia , 2013, Molecular Psychiatry.

[10]  F. Dickerson,et al.  C-reactive protein is elevated in schizophrenia , 2013, Schizophrenia Research.

[11]  F. Gudé,et al.  Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity , 2013, PloS one.

[12]  J. Suvisaari,et al.  Mortality and Its Determinants in People With Psychotic Disorder , 2013, Psychosomatic medicine.

[13]  P. Whiteley,et al.  Gluten- and casein-free dietary intervention for autism spectrum conditions , 2012, Front. Hum. Neurosci..

[14]  E. Severance,et al.  Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia , 2012, Neurobiology of Disease.

[15]  M. Maes,et al.  Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. , 2012, Journal of affective disorders.

[16]  D. Cohen,et al.  Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome , 2012, Psychoneuroendocrinology.

[17]  Robert H. Yolken,et al.  Anti-Gluten Immune Response following Toxoplasma gondii Infection in Mice , 2012, PloS one.

[18]  E. Ruiz-Mateos,et al.  Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers. , 2012, The Journal of infection.

[19]  S. Kritchevsky,et al.  Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  L. Pont-Lezica,et al.  The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes , 2012, Journal of leukocyte biology.

[21]  D. Kelly,et al.  A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies , 2012, Schizophrenia Research.

[22]  M. Obermeier,et al.  Impaired monocyte activation in schizophrenia , 2012, Psychiatry Research.

[23]  D. Douek,et al.  Microbial translocation in HIV infection: causes, consequences and treatment opportunities , 2012, Nature Reviews Microbiology.

[24]  E. Severance,et al.  Gastrointestinal inflammation and associated immune activation in schizophrenia , 2012, Schizophrenia Research.

[25]  B. Leonard,et al.  The metabolic syndrome in schizophrenia: is inflammation a contributing cause? , 2012, Journal of psychopharmacology.

[26]  F. Dickerson,et al.  Markers of gluten sensitivity in acute mania: A longitudinal study , 2012, Psychiatry Research.

[27]  Mogens Vestergaard,et al.  Life expectancy and cardiovascular mortality in persons with schizophrenia , 2012, Current opinion in psychiatry.

[28]  M. Schwarz,et al.  Inflammation in schizophrenia. , 2012, Advances in protein chemistry and structural biology.

[29]  D. Kelly,et al.  Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity , 2012, Psychiatric Quarterly.

[30]  B. Kirkpatrick,et al.  Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.

[31]  A. Lucendo,et al.  Resolution of metabolic syndrome after following a gluten free diet in an adult woman diagnosed with celiac disease. , 2011, World journal of gastrointestinal pathophysiology.

[32]  D. Cowan,et al.  Association between bovine casein antibody and new onset schizophrenia among US military personnel , 2011, Schizophrenia Research.

[33]  S. Tangye,et al.  Inflammatory Mechanisms in Obesity , 2013 .

[34]  F. Dickerson,et al.  Markers of gluten sensitivity and celiac disease in bipolar disorder. , 2011, Bipolar disorders.

[35]  W. Nolen,et al.  BIOMARKERS OF NEUROLOGICAL AND PSYCHIATRIC DISEASE , 2011 .

[36]  D. Kelly,et al.  Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. , 2011, Schizophrenia bulletin.

[37]  W. Nolen,et al.  Immune and neuroimmune alterations in mood disorders and schizophrenia. , 2011, International review of neurobiology.

[38]  E. Severance,et al.  Immune activation by casein dietary antigens in bipolar disorder. , 2010, Bipolar disorders.

[39]  P. Mortensen,et al.  Autoimmune diseases, bipolar disorder, and non-affective psychosis. , 2010, Bipolar disorders.

[40]  F. Dickerson,et al.  Markers of Gluten Sensitivity and Celiac Disease in Recent-Onset Psychosis and Multi-Episode Schizophrenia , 2010, Biological Psychiatry.

[41]  F. Hu,et al.  A Marker of Endotoxemia Is Associated With Obesity and Related Metabolic Disorders in Apparently Healthy Chinese , 2010, Diabetes Care.

[42]  E. Severance,et al.  Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia , 2010, Schizophrenia Research.

[43]  F. Dickerson,et al.  Novel immune response to gluten in individuals with schizophrenia , 2010, Schizophrenia Research.

[44]  P. Whiteley,et al.  The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders , 2010, Nutritional neuroscience.

[45]  R. Drexhage,et al.  The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder , 2010, Expert review of neurotherapeutics.

[46]  Nancy E Morden,et al.  Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. , 2009, General hospital psychiatry.

[47]  K. Reichelt,et al.  The possibility and probability of a gut-to-brain connection in autism. , 2009, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[48]  R. Kahn,et al.  Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study. , 2009, Archives of general psychiatry.

[49]  Sefik Alkan,et al.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. , 2008, Gastroenterology.

[50]  M. Maes,et al.  The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. , 2008, Neuro endocrinology letters.

[51]  S. Saha,et al.  A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? , 2007, Archives of general psychiatry.

[52]  M. Černá,et al.  Gliadin Peptides Activate Blood Monocytes from Patients with Celiac Disease , 2007, Journal of Clinical Immunology.

[53]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[54]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[55]  O. Mors,et al.  Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. , 2006, The American journal of psychiatry.

[56]  C. Hennekens,et al.  Schizophrenia and increased risks of cardiovascular disease. , 2005, American heart journal.

[57]  P. Thompson,et al.  Modulatory effects of sCD14 and LBP on LPS-host cell interactions , 2005, Journal of endotoxin research.

[58]  F. Powrie,et al.  Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.

[59]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[60]  H. Graff,et al.  Celiac syndrome in the case histories of five schizophrenics , 1961, Psychiatric Quarterly.

[61]  Z. Flegelová,et al.  Gliadin stimulates human monocytes to production of IL‐8 and TNF‐α through a mechanism involving NF‐κB , 2004 .

[62]  K. Miyake.  Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. , 2004, Trends in microbiology.

[63]  R. Yolken,et al.  Antibodies to infectious agents in individuals with recent onset schizophrenia , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[64]  Z. Flegelová,et al.  Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. , 2004, FEBS letters.

[65]  S. Virgiliis,et al.  Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function , 2003, Gut.

[66]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[67]  T. Roger,et al.  Initial responses to endotoxins and Gram-negative bacteria. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[68]  Lazz.  DSM-IV - 1994 , 1994 .

[69]  Dohan Fc.  Celiac disease and schizophrenia. , 1980 .

[70]  F. Dohan.  Celiac disease and schizophrenia. , 1980, The New England journal of medicine.

[71]  D. Challacombe.  Coeliac disease and schizophrenia. , 1971, Lancet.

[72]  F. Dohan.  WARTIME CHANGES IN HOSPITAL ADMISSIONS FOR SCHIZOPHRENIA , 1966 .

[73]  F. Dohan.  Wartime changes in hospital admissions for schizophrenia. A comparison of admission for schizophrenia and other psychoses in six countries during World War II. , 1966, Acta psychiatrica Scandinavica.